Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
VIR | Vir Biotechnology, Inc. | EVP and Chief Medical Officer | $1.05M | Jul 15, 2024 | ||
FGEN | FIBROGEN INC | EVP, Chief Medical Officer | $122K | Sep 6, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|